Predictability of nonremitting depression after first 2 weeks of antidepressant treatment: a VAST-D trial report

PB Hicks, V Sevilimedu, GR Johnson… - … and clinical practice, 2019 - Am Psychiatric Assoc
Objective: In this secondary analysis of data from the Veterans Affairs Augmentation and
Switching Treatments for Improving Depression Outcomes (VAST-D) study, the authors …

Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial

S Nakajima, H Uchida, T Suzuki, K Watanabe… - Progress in Neuro …, 2011 - Elsevier
RATIONALE: Treatment guidelines for major depressive disorder (MDD) recommend a
continuous use of antidepressants for several weeks, while recent meta-analyses indicate …

Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications

E Lilly - J Clin Psychiatry, 2007 - psychiatrist.com
Background: A subset of patients experience worsening of depressed mood after beginning
antidepressant treatment, which could represent the natural history of the illness or a …

How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placebo

GD Tollefson, SL Holman - International clinical …, 1994 - journals.lww.com
The onset of action of antidepressant medications is commonly believed to require three or
more weeks based on clinical observation and corollary receptor-based hypotheses …

First admissions for depression: is theno-treatment interval'a critical predictor of time to remission?

N Gormley, D O'Leary, F Costello - Journal of affective disorders, 1999 - Elsevier
Background: This study aimed to replicate findings that length of episode prior to adequate
antidepressant treatment (theno-treatment interval') and premorbid neuroticism predict time …

Predicting treatment response in major depressive disorder: the impact of early symptomatic improvement

PA Kudlow, DS Cha… - The Canadian Journal of …, 2012 - journals.sagepub.com
Objective: Antidepressants (ADs) are the mainstay of treatment for major depressive
disorder (MDD). Despite their widespread usage, a consensus does not exist as to the …

Symptom clusters as predictors of late response to antidepressant treatment

MH Trivedi, DW Morris, BD Grannemann… - Journal of Clinical …, 2005 - psychiatrist.com
Objective: While there is some indication from studies in the acute phase of antidepressant
treatment that there are differences in the timing of improvement in symptoms, relatively little …

Evidence of early onset of antidepressant effect in randomized controlled trials

SM Stahl, AA Nierenberg… - Journal of Clinical …, 2001 - psychiatrist.com
Although antidepressant medications are effective in approximately 70% of patients with
major depressive disorder, they have a delayed onset of therapeutic effect. This latency is …

Clinical features and drug induced side effects in early versus late antidepressant responders

C Fabbri, A Marsano, M Balestri, D De Ronchi… - Journal of psychiatric …, 2013 - Elsevier
Early antidepressant response (2nd week) has been reported as the result of a true
antidepressant effect and a predictor of subsequent stable response. With the purpose to …

Chronological milestones to guide drug change: when should clinicians switch antidepressants?

FM Quitkin, PJ McGrath, JW Stewart… - Archives of General …, 1996 - jamanetwork.com
Background: We attempt to identify the time when patients whose conditions are unimproved
while receiving antidepressants are unlikely to respond and should have their treatment …